医学
冲程(发动机)
改良兰金量表
灌注扫描
灌注
心脏病学
急性中风
内科学
随机化
闭塞
溶栓
随机对照试验
临床试验
析因分析
放射科
疾病严重程度
外科
脑灌注压
心理干预
纤溶剂
荟萃分析
梗塞
脑缺血
作者
Umberto Pensato,Gunjan Jindal,William Diprose,Aravind Ganesh,Pattarawut Charatpangoon,Ethan MacDonald,Alexander Stebner,Salome Bosshart,Dar Dowlatshahi,David Volders,James Kennedy,Markus Möhlenbruch,Brian H Buck,Shahid Nimjee,Thomas Booth,Mouhammad Jumaa,Jai Shankar,Franziska Dorn,Andrew M. Demchuk,Mayank Goyal
出处
期刊:JAMA network open
[American Medical Association]
日期:2026-10-13
卷期号:9 (10): e2638823-e2638823
标识
DOI:10.1001/jamanetworkopen.2026.38823
摘要
Importance: Recent trials have not demonstrated a benefit of endovascular thrombectomy (EVT) over medical therapy in acute stroke due to medium vessel occlusion (MeVO). However, it remains uncertain whether selected patients with favorable perfusion may benefit from EVT. Objective: To investigate the association between perfusion mismatch profiles and functional outcomes in MeVO stroke and to determine whether these profiles modify the effect of EVT. Design, Setting, and Participants: This study was a post hoc analysis of ESCAPE-MeVO (Endovascular Treatment to Improve Outcomes for Medium Vessel Occlusion), a multicenter randomized clinical trial conducted in North America, Europe, and the United Kingdom between April 2022 and June 2024, with a 90-day follow-up. Trial participants included patients with acute MeVO stroke presenting within 12 hours from last known well and evidence of salvageable brain tissue. This analysis included only patients with interpretable baseline perfusion imaging. Data were analyzed from March to July 2026. Interventions: Randomization to EVT plus usual care vs usual care alone. Main outcomes and measures: The primary outcome was the 90-day ordinal modified Rankin Scale (mRS) score. Secondary outcomes included 24-hour follow-up infarct volume and 90-day mRS score of 0 to 1 and 0 to 2. Perfusion mismatch ratio and volume were defined as the ratio and difference between the critically hypoperfused area and the ischemic core, with volume thresholds defined by site-specific postprocessing software. Results: Of 530 enrolled patients, 309 (58.3%) had available baseline perfusion imaging and were included in this study (EVT: n = 146; usual care: n = 163). Patient median (IQR) age was 73 (63-82) years, and 141 (45.6%) were women. Median (IQR) perfusion mismatch volume was 37.2 (22.1-57.2) mL, and the median (IQR) mismatch ratio was 6.1 (2.8-10.0). Ordinal 90-day mRS score was not associated with perfusion mismatch volume (adjusted odds ratio [AOR], 1.03 [95% CI, 0.99-1.07] per 10-mL increase) or perfusion mismatch ratio (AOR, 1.03 [95% CI, 0.97-1.09] per 1-unit increase). There was no modification of EVT effect by perfusion mismatch volume or ratio on ordinal 90-day mRS. Results were consistent across secondary outcomes and subgroups. Conclusions and Relevance: In this exploratory post hoc analysis of acute MeVO stroke, perfusion mismatch profiles were not associated with functional outcomes and did not modify the effect of EVT. These findings suggest that perfusion imaging profiles based on currently used thresholds and cutoffs did not identify patients likely to benefit from EVT in the ESCAPE-MeVO trial. Trial Registration: ClinicalTrials.gov Identifier: NCT05151172.
科研通智能强力驱动
Strongly Powered by AbleSci AI